Appointments

Robert C. Moellering, Jr., named to Ricerca's scientific advisory board

Published in Gene Therapy Weekly, September 19th, 2002

Ricerca Biosciences, LLC, a premier drug development partner to biotechnology and pharmaceutical companies, announced the appointment of Robert C. Moellering, Jr., MD, to its scientific advisory board for infectious diseases.

Ricerca Biosciences also announced the launch of its infectious diseases program by in-licensing from Genset the entire genomic sequences of Chlamydia pneumoniae and Chlamydia trachomatis, two important pathogenic bacteria.

Robert C. Moellering, Jr., is the Herrman L. Blumgart professor of medicine at Harvard Medical School and physician-in-chief and chairman of the department of medicine at the Beth Israel...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-09-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry